NSC001 clinical trials

A Study to Assess Safety and Tolerability and to Explore Efficacy of NSC001 in Mild to Moderate Alzheimer's Disease

This study is looking into a new medication called NSC001 for people with mild to moderate Alzheimer's disease. Researchers want to see if it's safe, how well people tolerate it, and if it could help improve memory and thinking.